ATE1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.5026699999976E-05 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.721960E-03 |
Normal-vs-Stage2 |
1.110210E-02 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
4.238300E-02 |
Stage1-vs-Stage2 |
7.367400E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
8.176400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.943400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.38750000000665E-05 |
Normal-vs-AfricanAmerican |
1.39579999780537E-08 |
Normal-vs-Asian |
1.019220E-03 |
Caucasian-vs-AfricanAmerican |
2.811600E-04 |
Caucasian-vs-Asian |
6.775200E-01 |
AfricanAmerican-vs-Asian |
8.619500E-03 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.163900E-03 |
Normal-vs-Female |
3.995800E-04 |
Male-vs-Female |
3.807000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.653500E-02 |
Normal-vs-Extreme_Weight |
3.541700E-03 |
Normal-vs-Obese |
2.428200E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
8.276200E-01 |
Normal_Weight-vs-Obese |
6.273400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
3.908800E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.1805999999589E-06 |
Normal-vs-Age(41-60Yrs) |
4.066400E-02 |
Normal-vs-Age(61-80Yrs) |
2.427900E-04 |
Normal-vs-Age(81-100Yrs) |
8.894100E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.651700E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.019800E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.273700E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.209000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.086000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.002200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
6.807400E-01 |
Normal-vs-Grade 3 |
6.633400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
7.029800E-01 |
Grade 2-vs-Grade 4 |
6.807400E-01 |
Grade 3-vs-Grade 4 |
6.633400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.559700E-04 |
Normal-vs-N1 |
1.013370E-04 |
N0-vs-N1 |
4.579000E-01 |
|
|